Table 1 Characteristics of the study population based on KORA F4, persons aged 40-65 years with blood pressure measurements and lung function tests
From: High blood pressure, antihypertensive medication and lung function in a general adult population
Men (N = 618) | Women (N = 701) | ||
|---|---|---|---|
Mean ± SD | Mean ± SD | P-Value# | |
Age (years) | 51.6 ± 5.8 | 51.5 ± 5.6 | 0.83 |
BMI (kg/m2) | 28.0 ± 4.5 | 26.9 ± 5.2 | <0.01 |
Packyears (y) | 21.8 ± 20.1 | 13.4 ± 12.9 | <0.01 |
Blood pressure | |||
Mean SBP (mm Hg) | 126.3 ± 16.1 | 114.9 ± 15.8 | <0.01 |
Mean DBP (mm Hg) | 80.1 ± 9.8 | 74.1 ± 9.0 | <0.01 |
Lung function | |||
FEV1 (l) | 3.9 ± 0.7 | 2.8 ± 0.5 | <0.01 |
FVC (l) | 5.0 ± 0.8 | 3.6 ± 0.6 | <0.01 |
FEV1 % predicted$ | 107.2 ± 16.2 | 110.1 ± 17.2 | <0.01 |
FVC % predicted$ | 111.5 ± 13.7 | 120.2 ± 16.0 | <0.01 |
n (%) | n (%) | P-Value # | |
Pulmonary and cardiac diseases | |||
Asthma | 50 (8.1) | 69 (9.8) | 0.27 |
Chronic bronchitis | 49 (8.0) | 58 (8.3) | 0.81 |
Heart attack | 17 (2.8) | 11 (1.6) | 0.14 |
Stroke | 15 (2.4) | 2 (0.3) | <0.01 |
Smoking status | |||
current | 155 (25.1) | 150 (21.4) | 0.11 |
former | 268 (43.4) | 236 (33.7) | <0.01 |
never | 195 (31.6) | 315 (45.0) | <0.01 |
High blood pressure and medication*classes | |||
HBP | 143 (23.1) | 72 (10.3) | <0.01 |
HBP or medication* | 221 (35.8) | 177 (25.3) | <0.01 |
HBP and medication* | 46 (7.4) | 22 (3.1) | <0.01 |
Only HBP | 97 (15.7) | 50 (7.1) | <0.01 |
Only medication*for HBP | 78 (12.6) | 105 (15.0) | 0.22 |
Medication* for HBP | 124 (20.1) | 127 (18.1) | 0.37 |
Beta-blocker | 68 (11.4) | 82 (11.8) | 0.67 |
ACE inhibitor | 52 (8.4) | 44 (6.3) | 0.14 |
Angiotensin antagonists | 41 (6.6) | 33 (4.7) | 0.13 |
Diuretics | 63 (10.2) | 60 (8.6) | 0.32 |
Calcium antagonists | 25 (4.1) | 25 (3.6) | 0.65 |
Other antihypertensive drugs | 3 (0.5) | 4 (0.6) | 0.83 |